Anjali Vaze
Anjali Vaze publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, on topics such as HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #976,938 of 7,710,434 ranked researchers
- Rank in United States
- #319,840 of 1,627,098
- Works
- 45
- Citations
- 805
- Citations per work
- 17.9
What does Anjali Vaze research?
Anjali Vaze's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2862.2%
- Medicine2862.2%
- Everything else1328.7%
- Life Sciences49.1%
- 1Oncology26% of their works
- 2Pulmonary and Respiratory Medicine11% of their works
- 3Radiology, Nuclear Medicine and Imaging11% of their works
- 4Molecular Biology9% of their works
- 5Reproductive Medicine8% of their works
- 6Genetics8% of their works
Research topics
Which keywords describe Anjali Vaze's research?
The keywords of their largest research topics: Breast Cancer, Chemotherapy, Metastatic Breast Cancer, HER2, Trastuzumab, CDK4/6 Inhibitors, Fc Receptors and Genomic Analysis.
- International Myeloma Working Group
- Diagnosis Criteria
- Chimeric Antigen Receptor
- CAR T Cells
- Palbociclib
- Genomic Analysis
- CDK4/6 Inhibitors
- HER2
- Chemotherapy
- Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab
- Fc Receptors
- Ovarian Cancer
- Therapeutic Antibodies
- Chemotherapy-Induced Peripheral Neuropathy
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Breast Cancer112 topics
- Chemotherapy112 topics
- Metastatic Breast Cancer82 topics
- HER261 topic
- Trastuzumab61 topic
- CDK4/6 Inhibitors51 topic
- Fc Receptors51 topic
- Genomic Analysis51 topic
- Ovarian Cancer51 topic
- Palbociclib51 topic
- Therapeutic Antibodies51 topic
- CAR T Cells31 topic
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- Chimeric Antigen Receptor31 topic
- Chronic Lymphocytic Leukemia31 topic
- Diagnosis Criteria31 topic
- Genomic Aberrations31 topic
- International Myeloma Working Group31 topic
- Taxanes31 topic
Where does Anjali Vaze work?
Anjali Vaze's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Anjali Vaze have?
OpenAlex counts 45 works and 805 citations for Anjali Vaze, an h-index of 14, ranking #976,938 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anjali Vaze. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.